PHARMA LITERATI

The dates for the most awaited exam are out. Please see the advert and note that online registration has already started. However the last date for online registration is 13 th May 2016. The D-day is 12 th June 2016. Please follow the link:  http://www.niper.gov.in/JEE%202016.pdf Subscribe us for more such information and remain up to date with the happenings in Pharma world! 

The HRD Ministry has worked out an agreement between All India Council for Technical Education (AICTE) and Pharmacy Council of India (PCI) to settle "regulatory discord" over running of pharmacy colleges. According to official sources, there are over 1,000 pharmacy colleges in the country which are regulated by AICTE while PCI, which comes under the Health Ministry, lays down norms for them. "There have been instances when the two bodies are not on the same page on key matters like fixing the number of seats in colleges. It is a case of jurisdictional overlapping. Recently, the Calcutta High Court had directed the HRD Ministry to resolve the conflict between these two regulatory bodies," an official source told. HRD Minister Secretary V S Oberoi had held a meeting with top officials of AICTE and PCI last week to discuss the issues following the high court order, the sources said. To create greater synergy between the two bodies, it has been decide...

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application No Inventors Institute Novel napthalimide- benzimidazole hybirds as potential anticancer agents and process for the preparation thereof 517/DEL/2008A 1) Ahmed Kamal 2) Pogula Praveen Kumar Council of Scientific and Industrial Research Polymer based drug delivery system 3278/MUM/2014A 1) Prof. Rohit Srivastava 2) Pawar Vaishali Pundlik 3) Dr. Arun Mullaji 4) Dr. Gautam Shetty IIT, Delhi Naturally derived ...

We started with the   share your experience   initiative recently. Please see:   http://pharmaliterati.blogspot.in/2016/04/share-your-experience.html Herein we post another piece of experience by Ms. Raeesa Gupte, who is currently working as an academic post-doc at University of Kansas Medical Center. She has obtained her B. Pharma from university of Mumbai and MS and PhD from US. Her profile can be accessed here:   https://www.linkedin.com/in/raeesagupte Networking at Conferences like a Pro! Last year I attended the Society for Neuroscience (SfN) meeting in Chicago. I had just graduated, was looking for a job and was attending the conference on my personal funds. So I was super-motivated to charm everybody I met till they offered me a job! There was only one problem. I was an introvert who didn’t know the first thing about networking. So I did what we academics are best at – I did some research. I read articles from Forbes, The Muse, The ...

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application No Inventors Institute A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery 2895/DEL/2014A 1) Amlan Chakraborty 2) Pranav Patni 3) Dr. SS Lahiri Amity University Preparation method of delay release multi-drugs component oral disintegrate tablets for cough 2159/DEL/2014A 1) Tulshi Chakraborty 2) Vipin Saini 3) Sumeet Gupta 4) Sakshi Sharma ...

Drug Name K-134 Structure   Drug Code K-134 Synonym OPC-33509 1-cyclopropyl-1-(2-hydroxycyclohexyl)-3-[3-[(2-oxo-1H-quinolin-6-yl)oxy]propyl]urea Molecular Formula C 22 H 29 N 3 O 4 Innovator D. Western Therapeutics Institute Kowa Company, Ltd. Condition Arteriosclerosis obliterans Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors (PDE3 inhibitor) Clinical Phase IIb in US

Drug Name Vernakalant Structure   Drug Code RSD1235 Synonym Kynapid, Brinavess (3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy] cyclohexyl}pyrrolidin-3-ol Molecular Formula C 20 H 31 NO 4 Innovator Cardiome Pharma Corp Merck Condition Prevention of post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery. Mechanism of Action Blocks atrial potassium and sodium channels Clinical Phase Not yet approved. (Filed for Orphan Drug Designation) Approved in Europe.

Drug Name Etripamil Structure   Drug Code MSP-2017 Synonym methyl 3-(2-{[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl](methyl)amino}ethyl)benzoate Molecular Formula C 27 H 36 N 2 O 4 Innovator Milestone Pharmaceuticals Condition Acute episodes of paroxysmal supraventricular tachycardia Mechanism of Action Calcium channel antagonist (Intranasal) Clinical Phase II in USA

Drug Name Eleclazine Structure   Drug Code GS-6615 Synonym 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy) phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one Molecular Formula C 21 H 16 F 3 N 3 O 3 Innovator Gilead Sciences Condition Cardiomyopathy Mechanism of Action Sodium channel antagonists Clinical Phase III in USA

In response to our ‘Share your experience’ initiative, Saloni Daftardar kindly agreed to write a post for us. She is an MS Candidate at College of Pharmacy of the Toledo University, Ohio. The Grad School: Journey So Far… Today, research is an international pursuit which has opened myriad of opportunities for us, students, to explore and invent new ideas which will provide an impetus to opening the boundaries in drug development and drive the needed breakthroughs. Once we choose to study abroad, we get our own share of experiences and challenges that make this “journey”, exciting, difficult but highly rewarding. Here are some of the lessons I learnt as I march forward in my journey as a pharmacy student in US. The curriculum The first year of school primarily focuses on laying a foundation for Industrial Pharmacy with courses such as advanced drug delivery systems, physical pharmacy, toxicokinetics, dosage form design and advanced analytical techniques. I have realised tha...